TuHURA Biosciences, Inc./NV (HURA) — research page
US · us-cm-kg/NASDAQ/HURA · as of 2026-11-08
Identity and listing
The issuer is TuHURA Biosciences, Inc./NV, listed on NASDAQ under ticker HURA, with ISIN US8989201038 and LEI 549300N7OBMRNSOQC133. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Nevada. Its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | TuHURA Biosciences, Inc./NV | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | HURA | source · 2026-11-08 |
| ISIN | US8989201038 | source · 2026-10-14 |
| LEI | 549300N7OBMRNSOQC133 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Nevada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 51 filings in the twelve months to 2026-11-08, across 33 filing days. The median gap between filing days is 8.5 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is dated 2026-11-06, an ad hoc filing, 2 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filings in the window is 52, and the sector median is 63.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 51 | 8.5 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | ad_hoc | 8-K | 8-K — 8-K (items 2.03,9.01) |
| 2026-10-16 | ad_hoc | 8-K | 8-K — 8-K (items 2.03,9.01) |
| 2026-09-24 | ad_hoc | 8-K | 8-K — 8-K (items 2.03,9.01) |
| 2026-09-17 | ad_hoc | 8-K | 8-K — 8-K (items 2.03,9.01) |
| 2026-09-17 | director_change | 8-K/A | 8-K/A — 8-K/A (items 5.02,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record; the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change events. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 6 research houses: Brookline Capital Markets, Citizens, H.C. Wainwright & Co., Maxim Group, Rodman & Renshaw, and Zacks SCR.
| research house | analyst | source · read date |
|---|---|---|
| Brookline Capital Markets | Kumaraguru Raja, PhD | issuer page · 2026-11-11 |
| Citizens | Silvan Turkcan, PhD | issuer page · 2026-11-11 |
| H.C. Wainwright & Co. | Robert Burns | issuer page · 2026-11-11 |
| Maxim Group | Jason McCarthy, PhD | issuer page · 2026-11-11 |
| Rodman & Renshaw | Michael King | issuer page · 2026-11-11 |
| Zacks SCR | John D. Vandermosten, CFA | issuer page · 2026-11-11 |
Open research
The state is none found. No openly published research notes are on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds the issuer's sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date at 2021-01-04. The live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001498382.json (identity.jurisdiction)
- 10.4
- https://api.gleif.org/api/v1/lei-records/549300N7OBMRNSOQC133 (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/HURA (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://ir.tuhurabio.com/stock-data/analyst-coverage (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/HURA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US8989201038"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:6b160e4fcd499841.